You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020156017
Dec 20204005
Jan 20212801
Feb 20212404
Mar 20214205
Apr 20213403
May 20211002
Jun 2021004
Jul 2021006
Aug 2021003
Sep 2021006
Oct 202130023
Nov 202140018
Dec 20211606
Jan 20222202
Feb 20221403
Mar 20223205
Apr 20226609
May 20225606
Jun 20224205
Jul 20224005
Aug 20224403
Sep 20223802
Oct 20223603
Nov 20221801
Dec 20225001
Jan 20233402
Feb 20234601
Mar 20236203
Apr 20234608
May 20234207
Jun 20234404
Jul 20234607
Aug 20233802
Sep 202332014
Oct 20231202
Nov 20235804
Dec 20234402
Jan 20241400
Feb 20243000
Mar 20246802
Apr 20242800
May 20242802
Jun 20244401
Jul 20249604
Aug 20241802
Sep 20241802
Oct 20243404
Nov 20244202
Dec 20242408
Jan 202540010
Feb 2025404
Apr 2025002
May 2025005
Jun 2025103
Total18710255